Neuroprotection of co-activation of GABA receptors by preventing caspase-3 denitrosylation in KA-induced seizures

Brain Research Bulletin

Volumn 88, Issue 6, 2012, Pages 617-623

  Wei, Xue Wen ^a   Yan, Hui ^a   Xu, Bo ^a   Wu, Yong Ping ^a   Li, Chong ^a   Zhang, Guang Yi ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Caspase 3; Denitrosylation; Fas FasL; GABA receptor; Kainic acid; Seizure

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ACTIN; BACLOFEN; CASPASE 3; FAS ANTIGEN; FAS LIGAND; KAINIC ACID; MUSCIMOL; PROCASPASE 3; THIOREDOXIN REDUCTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DENSITY; CELL SURVIVAL; CONTROLLED STUDY; CYTOSOL; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; MALE; MITOCHONDRION; NERVE CELL; NERVE CELL LESION; NEUROPROTECTION; NITROSYLATION; NONHUMAN; PREMEDICATION; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; RAT; SEIZURE; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; BACLOFEN; CA1 REGION, HIPPOCAMPAL; CA3 REGION, HIPPOCAMPAL; CASPASE 3; CONVULSANTS; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; ENZYME ACTIVATION; FAS LIGAND PROTEIN; GABA-A RECEPTOR AGONISTS; GABA-B RECEPTOR AGONISTS; KAINIC ACID; MALE; MUSCIMOL; NEUROPROTECTIVE AGENTS; NEUROTOXINS; NITROSATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA; SEIZURES; SULFHYDRYL COMPOUNDS; THIOREDOXIN-DISULFIDE REDUCTASE;

EID: 84864095486     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2012.05.008     Document Type: Article

References (43)

1. Baraka A.M., Hassab El Nabi W., El Ghotni S. Investigating the role of zinc in a rat model of epilepsy. CNS Neuroscience & Therapeutics 2011.
2. Ben-Ari Y. Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience 1985, 14:375-403.
3. Ben-Ari Y., Cossart R. Kainate a double agent that generates seizures: two decades of progress. Trends in Neurosciences 2000, 23:580-587.
4. Benhar M., Forrester M.T., Hess D.T., Stamler J.S. Regulated protein denitrosylation by cytosolic and mitochondrial thioredoxins. Science 2008, 320:1050-1054.
5. Benhar M., Forrester M.T., Stamler J.S. Protein denitrosylation: enzymatic mechanisms and cellular functions. Nature Reviews Molecular Cell Biology 2009, 10:721-732.
6. Chang B.S., Lowenstein D.H. Epilepsy. New England Journal of Medicine 2003, 349:1257-1266.
7. Chen J., Nagayama T., Jin K., Stetler R.A., Zhu R.L., Graham S.H., Simon R.P. Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia. Journal of Neuroscience 1998, 18:4914-4928.
8. Chen J.W., Wasterlain C.G. Status epilepticus: pathophysiology and management in adults. The Lancet Neurology 2006, 5:246-256.
9. Choi D.W. Excitotoxic cell death. Journal of Neurobiology 1992, 23:1261-1276.
10. Costa C., Leone G., Saulle E., Pisani F., Bernardi G., Calabresi P. Coactivation of GABA(A) and GABA(B) receptor results in neuroprotection during in vitro ischemia. Stroke 2004, 35:596-600.
11. Earnshaw W.C., Martins L.M., Kaufmann S.H. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annual Review of Biochemistry 1999, 68:383-424.
12. Eldadah B.A., Faden A.I. Caspase pathways, neuronal apoptosis, and CNS injury. Journal of Neurotrauma 2000, 17:811-829.
13. Enari M., Sakahira H., Yokoyama H., Okawa K., Iwamatsu A., Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 1998, 391:43-50.
14. Faherty C.J., Xanthoudakis S., Smeyne R.J. Caspase-3-dependent neuronal death in the hippocampus following kainic acid treatment. Brain Research. Molecular Brain Research 1999, 70:159-163.
15. Frerking M., Nicoll R.A. Synaptic kainate receptors. Current Opinion in Neurobiology 2000, 10:342-351.
16. Fujikawa D.G. Prolonged seizures and cellular injury: understanding the connection. Epilepsy & Behavior 2005, 7(Suppl. 3):S3-S11.
17. Hess D.T., Matsumoto A., Kim S.O., Marshall H.E., Stamler J.S. Protein S-nitrosylation: purview and parameters. Nature Reviews Molecular Cell Biology 2005, 6:150-166.
18. Hill D.R., Bowery N.G. 3H-baclofen and 3H-GABA bind to bicuculline-insensitive GABA B sites in rat brain. Nature 1981, 290:149-152.
19. Holmgren A., Biochemistry SNO removal. Science 2008, 320:1019-1020.
20. Jackson-Friedman C., Lyden P.D., Nunez S., Jin A., Zweifler R. High dose baclofen is neuroprotective but also causes intracerebral hemorrhage: a quantal bioassay study using the intraluminal suture occlusion method. Experimental Neurology 1997, 147:346-352.
21. Jaffrey S.R., Erdjument-Bromage H., Ferris C.D., Tempst P., Snyder S.H. Protein S-nitrosylation: a physiological signal for neuronal nitric oxide. Nature Cell Biology 2001, 3:193-197.
22. Janicke R.U., Sprengart M.L., Wati M.R., Porter A.G. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. Journal of Biological Chemistry 1998, 273:9357-9360.
23. Kim Y.M., Talanian R.V., Billiar T.R. Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. Journal of Biological Chemistry 1997, 272:31138-31148.
24. Kumar S. Caspase function in programmed cell death. Cell Death and Differentiation 2007, 14:32-43.
25. Lerma J., Morales M., Vicente M.A., Herreras O. Glutamate receptors of the kainate type and synaptic transmission. Trends in Neurosciences 1997, 20:9-12.
26. Li C., Xu B., Wang W.W., Yu X.J., Zhu J., Yu H.M., Han D., Pei D.S., Zhang G.Y. Coactivation of GABA receptors inhibits the JNK3 apoptotic pathway via disassembly of GluR6-PSD-95-MLK3 signaling module in KA-induced seizure. Epilepsia 2010, 51:391-403.
27. Liu X.M., Pei D.S., Guan Q.H., Sun Y.F., Wang X.T., Zhang Q.X., Zhang G.Y. Neuroprotection of Tat-GluR6-9c against neuronal death induced by kainate in rat hippocampus via nuclear and non-nuclear pathways. Journal of Biological Chemistry 2006, 281:17432-17445.
28. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951, 193:265-275.
29. Mannick J.B., Hausladen A., Liu L., Hess D.T., Zeng M., Miao Q.X., Kane L.S., Gow A.J., Stamler J.S. Fas-induced caspase denitrosylation. Science 1999, 284:651-654.
30. McCarthy M.J., Rubin L.L., Philpott K.L. Involvement of caspases in sympathetic neuron apoptosis. Journal of Cell Science 1997, 110(Pt 18):2165-2173.
31. Nagata S. Fas ligand-induced apoptosis. Annual Review of Genetics 1999, 33:29-55.
32. Nikitovic D., Holmgren A. S-nitrosoglutathione is cleaved by the thioredoxin system with liberation of glutathione and redox regulating nitric oxide. Journal of Biological Chemistry 1996, 271:19180-19185.
33. Pan J., Zhang Q.G., Zhang G.Y. The neuroprotective effects of K252a through inhibiting MLK3/MKK7/JNK3 signaling pathway on ischemic brain injury in rat hippocampal CA1 region. Neuroscience 2005, 131:147-159.
34. Park H.J., Kim H.J., Ra J., Zheng L.T., Yim S.V., Chung J.H. Protective effect of topiramate on kainic acid-induced cell death in mice hippocampus. Epilepsia 2008, 49:163-167.
35. Pei D.S., Guan Q.H., Sun Y.F., Zhang Q.X., Xu T.L., Zhang G.Y. Neuroprotective effects of GluR6 antisense oligodeoxynucleotides on transient brain ischemia/reperfusion-induced neuronal death in rat hippocampal CA1 region. Journal of Neuroscience Research 2005, 82:642-649.
36. Perucca E. Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience. CNS Drugs 2002, 16:695-714.
37. Racine R.J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalography and Clinical Neurophysiology 1972, 32:281-294.
38. Sharma K., Wang R.X., Zhang L.Y., Yin D.L., Luo X.Y., Solomon J.C., Jiang R.F., Markos K., Davidson W., Scott D.W., Shi Y.F. Death the Fas way: regulation and pathophysiology of CD95 and its ligand. Pharmacology & Therapeutics 2000, 88:333-347.
39. Thornberry N.A., Lazebnik Y. Caspases: enemies within. Science 1998, 281:1312-1316.
40. Tian H., Zhang G., Li H., Zhang Q. Antioxidant NAC and AMPA/KA receptor antagonist DNQX inhibited JNK3 activation following global ischemia in rat hippocampus. Neuroscience Research 2003, 46:191-197.
41. Walczak H., Krammer P.H., The C.D95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems. Experimental Cell Research 2000, 256:58-66.
42. Wang Q., Yu S., Simonyi A., Sun G.Y., Sun A.Y. Kainic acid-mediated excitotoxicity as a model for neurodegeneration. Molecular Neurobiology 2005, 31:3-16.
43. Zhang F., Li C., Wang R., Han D., Zhang Q.G., Zhou C., Yu H.M., Zhang G.Y. Activation of GABA receptors attenuates neuronal apoptosis through inhibiting the tyrosine phosphorylation of NR2A by Src after cerebral ischemia and reperfusion. Neuroscience 2007, 150:938-949.